Related Experiment Video
Updated: May 22, 2025

04:53
Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining
Published on: June 23, 2020
30.0K
Asymmetric D-A-D' Ratiometric Molecule for Highly Specific Hypochlorous Acid Detection
Jinjin Che1, Hongjian Gong2, Axiu Yang1
1Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, China.
Analytical Chemistry
|March 13, 2025
Summary
This study introduces a novel fluorescent probe (PMT NPs) for highly specific detection of hypochlorous acid (HClO) over hypochlorite (ClO-). The probe
Area of Science:
- Chemical sensing
- Molecular probes
- Biomarker detection
Background:
- Hypochlorous acid (HClO) and hypochlorite (ClO-) share similar oxidative activities, complicating their differentiation.
- Accurate detection of HClO is crucial for understanding biological processes and diseases.
Purpose of the Study:
- To design a highly specific fluorescent probe for HClO detection.
- To achieve an optimized ratiometric response for accurate quantification.
Main Methods:
- Development of an asymmetric donor-acceptor-donor' (D-A-D') molecular architecture for the probe (PMT NPs).
- Modulation of electron acceptor properties to tune the probe's oxidation potential for HClO selectivity.
- Utilizing intramolecular charge transfer (ICT) shifts for ratiometric fluorescence signaling.
Main Results:
- The PMT NPs probe demonstrated exceptional specificity for HClO over ClO-.
- The probe exhibited an optimized ratiometric response with a controlled blue shift in fluorescence.
- Successful validation in live cell imaging and *in vivo* studies using zebrafish and mouse models.
Conclusions:
- The D-A-D' molecular design strategy enables precise HClO recognition in acidic environments.
- The developed probe allows real-time monitoring of HClO surges.
- This approach offers a promising platform for designing probes for various biomolecules and advancing disease research.

